Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

Intresserad av platformen MFN för nyhetsdistribution?

Onsdag 28 Oktober | 17:16:38 Europe / Stockholm

Svenska | English

Investor Relations

Public Relations

Redeye

Bifogade filer

XVIVO - In good shape with a few blemishes

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

XVIVO - In good shape with a few blemishes

2023-10-25 08:02:00

Redeye updates our outlook after Q3. XVIVO delivers improved gross and EBITDA margins and an overall organic growth of 42% (CER) which is very good by most comparisons. Thoracic disposables recorded sales below expectations mostly as a result of the strong Q3 2022 and a strong Q2 in 2023. The key Thoracic disposable gross margins improved by 4% to 85% in Q3. The outlook remains positive, and the important US Heart study has started. We reiterate our base case to SEK 450 with a Bull of SEK 900 and a Bear of SEK 105.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/